McDermott + Bull has successfully placed Matt Schweickert as Chief Financial Officer at Geneo. Matt will develop and execute Geneo’s corporate strategy while acting as a key interface with internal and external stakeholders. Additionally, he will oversee all aspects of the accounting and financial management systems, including the development, coordination, and implementation of financial policies, reports, and controls. 

Matt brings extensive experience in private equity sponsored companies, where he has helped accelerate profitable growth, built global consumer and retail brands, and developed diverse teams across a range of functions. Most recently, he served as Chief Financial Officer at Resident and was Chief Strategy Officer at The Home Depot before that. Throughout the course of his career, Matt has actively led or participated in more than 150 mergers and acquisitions. He earned a bachelor’s degree in international economics and investments from Babson College and an MBA in finance from the University of North Carolina at Chapel Hill. 

Geneo started from two great companies: Lumenis® and its subsidiary Pollogen®. Together, Pollogen and Lumenis created the perfect balance of science and artistry in Geneo®. Geneo partners directly with “Xtipreneurs,” entrepreneurial estheticians who are deemed as Geneo’s “X-factor.” Geneo’s new approach is putting estheticians at the heart of its global growth strategy and is committed to supporting each one of its Xtipreneurs and their business. 

This executive search was completed by McDermott + Bull Managing Partner + Co-Founder Chris Bull, Vice President Michael Sesker, Director Anne Terry, Executive Recruiter CJ Shook, and Research Associate Shayla Servantez.